SCHEMBL7876890

SCHEMBL7876890

CC(Cc1ccccc1)C[C@@H](C(=O)O)[C@H](Cn1ncnn1)N(O)C=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.38
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
POLB P06746 2/20 0.31
PTGS2 P35354 1/20 0.30
L3MBTL1 Q9Y468 2/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
PTPN7 P35236 1/20 0.30
RECQL P46063 1/20 0.30
BLM P54132 1/20 0.30
KMT2A Q03164 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7903959 0.73 ACE (0.53) ACESLC1A3SLC1A2SLC1A1
SCHEMBL7879178 0.71 ACE (0.39) ACESLC1A3SLC1A2SLC1A1PTGS2
SCHEMBL7879214 0.66 SLC1A3 (0.49) ACESLC1A3SLC1A2SLC1A1POLB
SCHEMBL4308700 0.63 POLB (0.40) SLC1A3SLC1A2SLC1A1POLBPTGS2
SCHEMBL6362101 0.61 SLC15A1 (0.50) ACESLC1A3SLC1A2SLC1A1POLB
SCHEMBL11210664 0.61 CYP1A2 (0.53) ACE
SCHEMBL17171334 0.61 CYP1A2 (0.53) ACE
SCHEMBL17171335 0.61 CYP1A2 (0.53) ACE
SCHEMBL7876539 0.61 SMN1; SMN2 (0.46) ACESLC1A3SLC1A2SLC1A1POLB
Hydrochloric Acid SCHEMBL4864811 0.60 SLC15A1 (0.49) ACESLC1A3SLC1A2SLC1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed